[go: up one dir, main page]

AU2001262520A1 - Combined preparation for the treatment of neoplasic diseases - Google Patents

Combined preparation for the treatment of neoplasic diseases

Info

Publication number
AU2001262520A1
AU2001262520A1 AU2001262520A AU6252001A AU2001262520A1 AU 2001262520 A1 AU2001262520 A1 AU 2001262520A1 AU 2001262520 A AU2001262520 A AU 2001262520A AU 6252001 A AU6252001 A AU 6252001A AU 2001262520 A1 AU2001262520 A1 AU 2001262520A1
Authority
AU
Australia
Prior art keywords
treatment
combined preparation
neoplasic diseases
neoplasic
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001262520A
Inventor
Selman Abdul-Halim Ali
June Lynam
Cornelia Suzanna Mclean
Robert Charles Rees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cantab Pharmaceuticals Research Ltd
Nottingham Trent University
Original Assignee
Cantab Pharmaceuticals Research Ltd
Nottingham Trent University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cantab Pharmaceuticals Research Ltd , Nottingham Trent University filed Critical Cantab Pharmaceuticals Research Ltd
Publication of AU2001262520A1 publication Critical patent/AU2001262520A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/428—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/50—Colon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001262520A 2000-06-06 2001-06-06 Combined preparation for the treatment of neoplasic diseases Abandoned AU2001262520A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0013817.2A GB0013817D0 (en) 2000-06-06 2000-06-06 Method for treating cells
GB0013817 2000-06-06
PCT/GB2001/002489 WO2001093901A1 (en) 2000-06-06 2001-06-06 Combined preparation for the treatment of neoplasic diseases

Publications (1)

Publication Number Publication Date
AU2001262520A1 true AU2001262520A1 (en) 2001-12-17

Family

ID=9893125

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001262520A Abandoned AU2001262520A1 (en) 2000-06-06 2001-06-06 Combined preparation for the treatment of neoplasic diseases

Country Status (7)

Country Link
US (1) US20020041869A1 (en)
EP (1) EP1289546A1 (en)
JP (1) JP2003535145A (en)
AU (1) AU2001262520A1 (en)
CA (1) CA2411285A1 (en)
GB (1) GB0013817D0 (en)
WO (1) WO2001093901A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785583B2 (en) * 2002-12-10 2010-08-31 Argos Therapeutics, Inc. In situ maturation of dendritic cells
US7638122B2 (en) * 2003-03-07 2009-12-29 University Of South Florida Stat3 antagonists and their use as vaccines against cancer
US7820628B2 (en) * 2005-02-22 2010-10-26 University Of Massachusetts Medical School Tumor lesion regression and conversion in situ into autologous tumor vaccines by compositions that result in anti-Gal antibody binding

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0811057B1 (en) * 1995-02-21 2006-04-26 Cantab Pharmaceuticals Research Limited Viral preparations, vectors, immunogens, and vaccines
US6602709B1 (en) * 1998-02-20 2003-08-05 The Rockefeller University Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
US6616925B1 (en) * 1998-04-02 2003-09-09 I.D.M. Immuno-Designed Molecules Combined preparation for the treatment of neoplasic diseases or of infectious diseases

Also Published As

Publication number Publication date
GB0013817D0 (en) 2000-07-26
US20020041869A1 (en) 2002-04-11
WO2001093901A1 (en) 2001-12-13
JP2003535145A (en) 2003-11-25
EP1289546A1 (en) 2003-03-12
CA2411285A1 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2001233208A1 (en) Human sulfatases
AU2001232787A1 (en) Airway alkalinization as therapy for airway diseases
AU2001260834A1 (en) The treatment of herpes
AU2001293891A1 (en) New combination for the treatment of asthma
AU2001284763A1 (en) Preparation of risperidone
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases
AU1405001A (en) Treatment of diseases
AU2002361190A1 (en) Preparation for the topical anaesthesia of the skin
AU3064800A (en) The therapeutic use of r-warfarin as anticoagulant
AU2001228863A1 (en) Remedies for ophthalmic diseases
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
AU6106801A (en) Trans-clitoral administration of therapy
AU2002215923A1 (en) Use of medicaments
AU2001253560A1 (en) Methods of treatment
AU4453301A (en) Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis
AU2002357964A1 (en) Use of coagulant-active antitrhombin iii for the therapy of angiogenesis-dependent diseases
AU2002216038A1 (en) Preparation of monofluoroalkenes
HK1057753A (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
AU2002231651A1 (en) Process for the preparation of morpholinones
AU2002300032A1 (en) Combination preparation for the therapy of immunological diseases